基本信息
浏览量:1
职业迁徙
个人简介
Dr Shirin Kalimuddin is clinically trained as an infectious disease specialist and currently holds the position of Consultant with the Department of Infectious Diseases at the Singapore General Hospital (SGH). She is also an Assistant Professor with the Emerging Infectious Diseases programme, Duke-NUS Medical School (Duke-NUS).
Dr Kalimuddin is currently at the forefront of clinical trials to study the safety and efficacy of therapeutics, for the treatment of COVID-19. She is also engaged in research to study the role of virological and host factors in determining COVID-19 outcome.
Her research spans basic, translational and clinical sciences. She investigates the role of the gut microbiome in the development of antibiotic-associated gastrointestinal adverse effects. She also studies the application of advanced imaging techniques on dengue patients to define sites of inflammation and plasma leakage. As a member of the Singapore Infectious Disease Clinical Research Network Executive Council, she is also actively involved in several clinical trials studying optimal therapeutic management for MRSA, Klebsiella and multidrug-resistant gram-negative bacterial infections.
In 2019, Dr Kalimuddin was awarded the NMRC Transition Award.
Dr Kalimuddin is currently at the forefront of clinical trials to study the safety and efficacy of therapeutics, for the treatment of COVID-19. She is also engaged in research to study the role of virological and host factors in determining COVID-19 outcome.
Her research spans basic, translational and clinical sciences. She investigates the role of the gut microbiome in the development of antibiotic-associated gastrointestinal adverse effects. She also studies the application of advanced imaging techniques on dengue patients to define sites of inflammation and plasma leakage. As a member of the Singapore Infectious Disease Clinical Research Network Executive Council, she is also actively involved in several clinical trials studying optimal therapeutic management for MRSA, Klebsiella and multidrug-resistant gram-negative bacterial infections.
In 2019, Dr Kalimuddin was awarded the NMRC Transition Award.
研究兴趣
论文共 38 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
PLoS Biologyno. 11 (2023): e3002351-e3002351
Hui Ling Ko, Nicole Zhuo,Zi Wei Chang,Anindita Santosa,Shirin Kalimuddin,Xin Rong Lim,Seow Yen Tan,David Chien Lye, Dorothy Toh,Barnaby Edward Young,Laurent Renia,Haur Yueh Lee,
Allergyno. 1 (2023): 304-307
Nick Anagnostou,Sophia Archuleta,Eugene Athan, Lauren Barina,Emma Best, Max Bloomfield, Jennifer Bostock,Carly Botheras,Asha Bowen,Philip Britton,Hannah Burden,Anita Campbell,
FRONTIERS IN IMMUNOLOGY (2022): 978760
biorxiv(2021)
Janessa Tan,Danielle E Anderson,Abhay P S Rathore, Aled O'Neill,Chinmay Kumar Mantri,Wilfried A A Saron,Cheryl Lee, Chu Wern Cui,Adrian E Z Kang,Randy Foo,Shirin Kalimuddin,Jenny G Low,
medRxiv : the preprint server for health sciences (2021)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn